We Are Reveles

As the founder and CEO, R'Kes is responsible for all aspects of strategic planning, corporate alliances, sales and marketing, operations, financial management, and regulatory compliance at Reveles Clinical Services. R'Kes has over17 years of leading high-touch pharmacy services, clinical operations, specialty drug distribution, and clinical research management to patients with rare and complex diseases such as Chronic Kidney disease, Cancer, Hemophilia, Cystic Fibrosis, and other complex diseases.

Prior to founding Reveles, R'Kes led McKesson's Specialty Pharmacy and Clinical Research Services businesses, which comprised of a large national, oncology-focused specialty pharmacy and the “central depot” that provides investigational product distribution, accountability, and storage for the US Oncology Research Network. He oversaw a multi-disciplinary clinical research team that has been involved in over 130 active oncology-focused clinical trials and was responsible for delivering over 50,000 annual shipments of investigational products, laboratory kits, and clinical supplies to the US Oncology network sites across the United States. Prior to McKesson, as the Vice President of Operations, he oversaw eight Home Infusion specialty pharmacies in six states with Coram CVS Specialty Infusion Services, which has translated into R'Kes having in-depth experience and knowledge of providing direct-to-patient care for thousands of patients on commercialized medications with complex and rare diseases in their homes.
 

R'Kes received his Executive Master’s in Business Administration from the Kellogg School Management, Northwestern University, and his bachelor’s degree from Purdue University in Pharmacy.